Showing results 1 to 20 of 43
next >
| Issue Date | Title | Author(s) |
| 2013 | Age 45 years and under in patients with multiple myeloma does not confer superior survival: a multicenter retrospective analysis in China | Lu, Jin; Hou, Jian; Chen, Wenming; Huang, Xiao-Jun |
| 2015 | The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis | Lu, Jing; Lu, Jin; Liu, Aijun; Fu, Weijun; Du, Juan; Huang, Xiaojun; Chen, Wenming; Hou, Jian |
| 2016 | Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China | Lu, Jin; Hou, Jian; Liu, Kai-Yan; Parmar, Simrit; De La Fuente, Adolfo; Andersson, Borje; Yan, ChenHua; Zhou, Daobin; Tan, Daryl; Ritchie, David; Wu, Deipei; Shpall, Elizabeth; Laport, Ginna G.; Li, JianYong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Issaragrisil, Surapol; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong; Rosengarten, Rafael; Steuernagle, Jon; Xiao, Jun Huang; Orlowski, Robert; Chim, Chor Sang |
| 15-Nov-2022 | Bortezomib-Decp Alternating with Daratumumab-Vpd Plus Stem Cell Transplantation, Followed By Maintenance with VP in Ultra-High Risk (UHiR) Newly Diagnosed Multiple Myeloma (NDMM) and Primary Plasma Cell Leukemia (pPCL): A Multicenter, Prospective Phase 2 P | Lu, Jin; Liu, Yang; Hou, Jian; Li, Juan |
| 2012 | Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial. | Chen, Wenming; Hou, Jian; Zhao, Yaozhong; Qiu, Lugui; Ke, Xiaoyan; Wang, Zhao; Leng, Yun; Jing, Hongmei; Xi, Hao; Zheng, Xiangjun; Wang, Fuxu; Zhu, Bing; Yang, Shifang |
| 2017 | Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study | Leng, Yun; Hou, Jian; Jin, Jie; Zhang, Mei; Ke, Xiaoyan; Jiang, Bin; Pan, Ling; Yang, Linhua; Zhou, Fang; Wang, Jianmin; Wang, Zhao; Liu, Li; Li, Wei; Shen, Zhixiang; Qiu, Lugui; Chang, Naibai; Li, Jianyong; Liu, Jing; Pang, Hongyan; Meng, Haitao; Wei, Peng; Jiang, Hua; Liu, Yan; Zheng, Xiangjun; Yang, Shifang; Chen, Wenming |
| Oct-2020 | Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN) | Liu, Jin; Hu, Xiaoxia; Jia, Yanchun; Lu, Jin; Lee, Jae Hoon; Kim, Kihyun; Chen, Wenming; Liu, Aijun; Liu, Yang; Chen, Qi; Zhang, Chunyang; Suh, Cheolwon; Kim, Min Kyoung; Zhou, Fan; Chng, Wee Joo; Kumar, Shaji K.; Durie, Brian; Hou, Jian; Fu, Weijun; Du, Juan |
| 2012 | Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study | Lee, Jae Hoon; Kim, Kihyun; Kim, Jin Seok; Min, Chang Ki; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chou, Takaaki; Kosugi, Hiroshi; Suzuki, Kenshi; Hata, Hiroyuki; Chen, Wenming; Hou, Jian; Lu, Jin; Huang, Shang-Yi; Chng, Wee-Joo; Tan, Daryl; Teoh, Gerrard; Chim, James Chor Sang; Siritanaratkul, Noppadol; Nawarawong, Weerasak; Durie, Brian G. M. |
| 2014 | Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study | Kim, Kihyun; Lee, Jae Hoon; Kim, Jin Seok; Min, Chang Ki; Yoon, Sung Soo; Shimizu, Kazuyuki; Chou, Takaaki; Kosugi, Hiroshi; Suzuki, Kenshi; Chen, Wenming; Hou, Jian; Lu, Jin; Huang, Xiao-Jun; Huang, Shang-Yi; Chng, Wee Joo; Tan, Daryl; Teoh, Gerrard; Chim, Chor Sang; Nawarawong, Weerasak; Siritanaratkul, Noppadol; Durie, Brian G. |
| Dec-2022 | A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs | Sun, Ying-Jie; Chen, Wen-Da; Liu, Ji; Li, Jun-Jin; Zhang, Yu; Cai, Wei-Qi; Liu, Li; Tang, Xin-Jing; Hou, Jian; Wang, Ming; Cheng, Liang |
| Nov-2022 | Development and Evaluation of Large-Size Phase Change Proppants for Fracturing of Marine Natural Gas Hydrate Reservoirs | Qu, Zhanqing; Fan, Jiacheng; Guo, Tiankui; Liu, Xiaoqiang; Hou, Jian; Wang, Meijia |
| May-2024 | The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR) | Aoki, Naomi; Chen, Pin-Yen; Chen, Wenming; Chng, Wee Joo; Gan, Gin Gin; Goh, Yeow Tee; Hou, Jian; Huang, Jeffrey; Kim, Kihyun; Lee, Je Jung; Lu, Jin; McQuilten, Zoe K.; Min, Chang Ki; Moore, Elizabeth; Oliver, Laura; Waters, Neil A.; Wellard, Cameron; Wood, Erica M.; Yeh, Su-Peng; Spencer, Andrew |
| Aug-2023 | Fast prediction method of displacement front in heterogeneous porous media using deep learning and orthogonal design | Zhao, Dong; Hou, Jian; Wei, Bei; Liu, Haihu; Du, Qingjun; Zhang, Yang; Sun, Zezheng |
| 2017 | Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China | Huang, Xiao Jun; Liu, Kaiyan; Ritchie, David; Andersson, Borje; Lu, Jin; Hou, Jian; Burguera, Adolfo de la Fuente; Wang, JianXiang; Yeoh, Allen; Yan, Chenhua; Zhou, Daobin; Tan, Daryl; Kim, Dong Wook; Wu, Depei; Shpall, Elizabeth; Kornblau, Stephen; Neelapu, Sattava; Hongeng, Suradej; Li, Jianyong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Hagemeister, Frederick; Westin, Jason; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong |
| Oct-2022 | How does phase behavior of surfactant/fluid/fluid systems affect fluid-fluid displacement in porous media? | Yang, Weipeng; Chu, Guoyu; Du, Yujing; Xu, Ke; Yao, Erdong; Liang, Tianbo; Wei, Bing; Yu, Haiyang; Hou, Jian; Lu, Jun |
| Feb-2021 | ImmunoPET imaging of multiple myeloma with [Ga-68]Ga-NOTA-Nb1053 | Wang, Cheng; Chen, Yumei; Hou, Yun Nan; Liu, Qiufang; Zhang, Di; Zhao, Haitao; Zhang, You; An, Shuxian; Li, Lianghua; Hou, Jian; Huang, Gang; Liu, Jianjun; Zhao, Yong Juan; Wei, Weijun |
| 2014 | Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients | Lin, MaoFang; Hou, Jian; Chen, WenMing; Huang, XiaoJun; Liu, ZhuoGang; Zhou, YuHong; Li, Yan; Zhao, Taiyun; Wang, LinNa; Wu, Kwang-Wei; Shen, ZhiXiang |
| Oct-2023 | Investigation of microflow mechanisms and emulsion size distribution in porous media | Wang, Huiyu; Wei, Bei; Hou, Jian; Sun, Zezheng; Du, Qingjun; Zhou, Kang |
| 2015 | Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment | Zhou, Dao-bin; Yu, Li; Du, Xin; Jin, Jie; Cai, Zhen; Chen, Fangping; Ke, Xiaoyan; Li, Xiao; Wu, Depei; Meng, Fanyi; Ai, Huisheng; Zhang, Jingshan; DeMarco, Dena; Chen, Nianhang; Mei, Jay; Wang, Jianmin; Hou, Jian |
| 2016 | Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program | Du, Xin; Jin, Jie; Cai, Zhen; Chen, Fangping; Zhou, Dao-bin; Yu, Li; Ke, Xiaoyan; Li, Xiao; Wu, Depei; Meng, Fanyi; DeMarco, Dena; Zhang, Jingshan; Mei, Jay; Hou, Jian |
